TaiwanJ Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
TaiwanJ Pharmaceuticals has a total shareholder equity of NT$57.4M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$62.4M and NT$5.0M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
| Interest coverage ratio | n/a |
| Cash | NT$48.64m |
| Equity | NT$57.35m |
| Total liabilities | NT$5.04m |
| Total assets | NT$62.39m |
Financial Position Analysis
Short Term Liabilities: 6549's short term assets (NT$53.9M) exceed its short term liabilities (NT$4.9M).
Long Term Liabilities: 6549's short term assets (NT$53.9M) exceed its long term liabilities (NT$119.0K).
Debt to Equity History and Analysis
Debt Level: 6549 is debt free.
Reducing Debt: 6549 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6549 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 6549 is forecast to have sufficient cash runway for 10 months based on free cash flow estimates, but has since raised additional capital.